Cargando…
Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53
Auranofin is a gold-containing compound classified by the World Health Organization as a clinically established rheumatoid arthritis therapeutic agent. Through drug screening for novel anticancer therapeutics, we unexpectedly identified auranofin as a potent anticancer agent against a p53-null ovari...
Autores principales: | PARK, SEE-HYOUN G, LEE, JUN GHAN, BEREK, JONATHAN S., HU, MICKE Y C.-T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151813/ https://www.ncbi.nlm.nih.gov/pubmed/25096914 http://dx.doi.org/10.3892/ijo.2014.2579 |
Ejemplares similares
-
Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo
por: Park, See-Hyoung, et al.
Publicado: (2016) -
FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage
por: Chung, Young Min, et al.
Publicado: (2012) -
Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation
por: Hu, Theodore, et al.
Publicado: (2014) -
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin
por: Kim, Hyun Young, et al.
Publicado: (2023) -
Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
por: Thangamani, Shankar, et al.
Publicado: (2016)